Recombinant Truncated Diphtheria toxin for Possible Therapeutic Applications

Simple item page
dc.contributor.authorKumar, Ashok
dc.date.accessioned2015-09-22T06:24:47Z
dc.date.accessioned2023-10-19T11:07:27Z
dc.date.available2015-09-22T06:24:47Z
dc.date.available2023-10-19T11:07:27Z
dc.date.issued2014
dc.descriptionSupervisor: Biplab Boseen_US
dc.description.abstractToxicity of Bacterial toxins , like diphtheria tocin has been widely utilized to create therapeutic agents that can kill target cells. For example, Immunotoxins have been developed by fusing antibodies to diphtheria toxin. Antibodies home the toxin to specific cells, overexpressing the antigens and the toxin kills the target cells. Many of these toxins have receptors on certain cells. However, the receptor-binding ability of such toxins remains largely unutilized.en_US
dc.identifier.otherROLL NO. 08610607
dc.identifier.urihttps://gyan.iitg.ac.in/handle/123456789/470
dc.language.isoenen_US
dc.relation.ispartofseriesTH-1245;
dc.subjectBIOSCIENCES AND BIOENGINEERINGen_US
dc.titleRecombinant Truncated Diphtheria toxin for Possible Therapeutic Applicationsen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
TH-1245_08610607.pdf
Size:
11.39 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
PhD Theses (Biosciences and Bioengineering)